Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Cardiol. Aug 26, 2021; 13(8): 348-360
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.348
Table 2 Patient characteristics

CTL
YKR
P value
Number of patients13099
Age, yr69.4 ± 0.868.5 ± 1.00.437
Female (%)20 (15.4)12 (12.1)0.481
BMI24.5 ± 0.324.7 ± 0.30.644
Hypertension (%)90 (69.2)74 (74.7)0.360
Diabetes mellitus (%)70 (53.8)49 (49.5)0.407
Dyslipidemia (%)94 (72.3)75 (75.8)0.791
Smoking history (%)78 (60.0)59 (59.6)0.950
Preoperative AF (%)4 (3.1)1 (1.0)0.261
NYHA1.6 ± 0.11.7 ± 0.10.725
LAD, mm37.3 ± 0.437.9 ± 0.50.316
LVDd, mm47.8 ± 0.549.1 ± 0.70.131
LVDs, mm32.0 ± 0.632.7 ± 0.80.537
IVST, mm9.7 ± 0.19.9 ± 0.10.266
PWT, mm9.8 ± 0.110.0 ± 0.10.195
LVEF, %61.0 ± 0.860.0 ± 1.40.540
Operation time, min253.6 ± 5.7248.4 ± 6.80.555
Intubation time, h6.7 ± 0.75.6 ± 0.40.176
Number of distal anastomosis3.2 ± 0.13.2 ± 0.10.964
Right gastroepiploic artery graft (%)66 (50.8)52 (52.5)0.793
Saphenous vein graft (%)47 (36.2)32 (32.3)0.470
Blood transfusion (%)23 (17.7)19 (19.2)0.662
Postoperative AF (%)31 (23.8)24 (24.2)0.936
ICU stay, d1.2 ± 0.01.2 ± 0.00.895
Hospital stay, d10.1 ± 0.310.7 ± 0.40.187